{"id":675,"date":"2025-01-29T13:00:06","date_gmt":"2025-01-29T11:00:06","guid":{"rendered":"https:\/\/sisu.ut.ee\/estcan\/?page_id=675"},"modified":"2026-09-14T19:23:49","modified_gmt":"2026-09-14T16:23:49","slug":"eunet-ccc","status":"publish","type":"page","link":"https:\/\/sisu.ut.ee\/estcan\/eunet-ccc\/","title":{"rendered":"EUnetCCC JA"},"content":{"rendered":"

The European Comprehensive Cancer Center Network Joint Action<\/strong><\/p>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n

EUnetCCC event \u201cAdvancing Equality and Excellence Across Diverse Healthcare Systems\u201d<\/strong><\/p>\n\n\n\n

Hestia Hotel Europa, Paadi 5, Tallinn<\/strong><\/p>\n\n\n\n

15.-16.09. 2026<\/strong><\/p>\n\n\n\n

DAY 1: 15.09.2026<\/strong><\/p>\n\n\n\n

8:30-9:00<\/strong> Registration & Coffee
9:00-9:15<\/strong> Welcome words from Kadi-Liis Veiman<\/strong>, head of Estonian Cancer Network ESTCAN, co-lead of capacity building work package and Thomas Dubois<\/strong>, Head of European & International affairs, INCA, EUnetCCC Coordinator<\/p>\n\n\n\n

9:15-10:40<\/strong> Session 1: Inequalities and barrier analysis<\/strong>
9.15-9.35 <\/strong>\u201cThe impact of inequalities on cancer incidence and mortality in Europe\u201d Diego Serraino<\/strong>, Alliance Against Cancer, Italy
9.35-9.50 <\/strong>\u201cHow becoming a CCC could help to overcome the inequalities in care?\u201d Tit Albrecht<\/strong>, National Institute of Public Health of Slovenia
9.50-10.05 <\/strong>\u201cPatient Involvement as a Dimension of Comprehensiveness in EUnetCCC\u201d Delia Nicoara<\/strong>, The Oncology lnstitute Prof. Dr. Ion Chiricuta, Romania
10.05-10.25 <\/strong>\u201cUnderstanding barriers when implementing the CCC standards\u201d Kadi-Liis Veiman<\/strong>, Estonian Cancer Network, Estonia
10.25-10.40 <\/strong>Q&A <\/p>\n\n\n\n

10:40-11:00<\/strong> Coffee break<\/p>\n\n\n\n

11:00-12:30 Session 2: Workshops on cancer research, clinical trials, regional inequalities and innovation <\/strong>
Cancer research 1:<\/strong> the discussion will focus on the key components of research strategy and ways how to effectively integrate research and care
Moderator: Rui Medeiros<\/strong>, IPO Porto,Portugal Clinical trials 1:<\/strong> the discussion will focus on establishing clinical trial infrastructure and what role international collaboration plays
Moderator: Elena Turola<\/strong>, AUSL-IRCCS di Reggio Emilia, Italy
Regional inequalities:<\/strong> the discussion will focus on how to identify and address regional inequalities in cancer prevention, care and outcomes, and what can be done
when the underlying causes extend beyond the cancer centre itself
Moderator: Isabel Portillo<\/strong>, Basque Health Research Institute, Spain
Innovation:<\/strong> the discussion will focus on the pathway to translate innovation into practice
Moderator: Terje Peetso<\/strong>, North Estonia Medical Centre, Estonia<\/p>\n\n\n\n

12:30-13:30<\/strong> Lunch<\/p>\n\n\n\n

13:30-14:45 Session 3: EUnetCCC Certification and Capacity Building: Pathways, Field Test Insights, and Support<\/strong>
13:30-13:50<\/strong> \u201cCertification pathway, lessons learned from field testing, different consortium configurations\u201d Mona Krichen<\/strong>, Haute Autorit\u00e9 de Sant\u00e9 (HAS), France
13:50-14:10<\/strong> \u201cSupport for certification journey, building the capacities to achieve CCC\u201d Nacho A\u00f1\u00f3n Andr\u00e9s<\/strong>, Catalan Institute of Oncology (ICO), Spain
14.10- 14:45<\/strong> Q&A<\/p>\n\n\n\n

14:45-15:20<\/strong> Coffee break<\/p>\n\n\n\n

15:20-16:50 Session 4: Workshops on cancer research, clinical trials and patient pathways<\/strong>
Cancer research 2: <\/strong>the discussion will focus on the research infrastructure and ways to provide protected time for clinicians
Moderator: Magora Torres<\/strong>, Vall d\u2019Hebron Institute of Oncology, Spain
Clinical trials 2:<\/strong> the discussion will focus on the establishment\/improvement of clinical trial management units and early phase clinical trials
Moderator: Edita Baltru\u0161kevi\u010dien\u0117<\/strong>, National Cancer Center Vilnius, Lithuania
Patient pathways:<\/strong> the discussion will focus on identifying barriers in developing patient pathways, how to overcome them and how to effectively implement pathways
Moderator: Rille Pihlak<\/strong>, Estonian Cancer Network, Estonia<\/p>\n\n\n\n

16:50 \u2013 17:15<\/strong> Reflections on the day<\/p>\n\n\n\n

19:00<\/strong> Network dinner at Olde Hansa restaurant (Vana turg 1, Tallinn)<\/p>\n\n\n\n

\u2026\u2026\u2026\u2026\u2026\u2026\u2026.<\/strong><\/p>\n\n\n\n

DAY 2: 16.09.2026<\/strong><\/p>\n\n\n\n

8:30-9:00<\/strong> Welcome coffee
9:00-9:30<\/strong> Wrap up of first day
Session 5: The importance of governance for a successful CCC<\/strong>
9:30-9:45<\/strong> \u201cThe importance of good governance for a successful CCC\u201d Peter Naredi<\/strong>, Sahlgrenska CCC, Sweden
9:45-10:15<\/strong> \u201cSmall member state and unique healthcare environment countries\u2019 examples on governance structure\u201d Merete Andreassen<\/strong>, University Hospital of North Norway; Am\u00e9lie Gaignaux<\/strong>, Institut National du Cancer, Luxembourg; M\u00e1ria Pourov\u00e1<\/strong>, National Cancer Institute, Slovakia
10:15-11:00<\/strong> Panel discussion on governance structures<\/strong>
Moderator: Peter Naredi<\/strong>, Sahlgrenska CCC, Sweden<\/p>\n\n\n\n

11:00-11:20<\/strong> Coffee break<\/p>\n\n\n\n

Session 6: Managing across institutional and legal boundaries<\/strong>
11:20-11:30<\/strong> \u201cFindings from the Collegial Interview Programme\u201d Susanne Pinnock<\/strong>, Oslo University Hospital, Norway
Practical examples:<\/strong>
11:30-12:00<\/strong> \u201cDeveloping governance across institutional boundaries: Governance within EUnetCCC Slovenia\u201d Tit Albreht<\/strong>, National Institute of Public Health of Slovenia
12:00- 12:15<\/strong> \u201cA model of consortium-based CCC governance, HUGO | ACCCESS example\u201d Gabrielle MANA\u00cf<\/strong>, HUGO Consortium, University Hospitals of Western France
12:15- 13:00<\/strong> Panel discussion and Q&A<\/strong>
Moderator: Susanne Pinnock<\/strong>, Oslo University Hospital, Norway
Panellists: Tit Albrecht<\/strong>, National Institute of Public Health of Slovenia; Peter Naredi<\/strong>, Sahlgrenska CCC, Sweden; Joan Prades<\/strong>, Catalan Institute of Oncology (ICO), Spain; Gabrielle MANA\u00cf<\/strong>, HUGO Consortium, University Hospitals of Western France
13:00-13:15<\/strong> Event summary<\/p>\n\n\n\n

12:50-\u2026<\/strong> Lunch<\/p>\n\n\n\n

\u2026\u2026\u2026\u2026\u2026\u2026\u2026.<\/strong><\/p>\n\n\n\n

The aim of the Joint Action European Network of Comprehensive Cancer Centres (EUnetCCC) is to connect comprehensive cancer centres across Europe to provide 90% of patients with access to the best cancer care, wherever they live. The network is a platform for centres across Europe to share and develop best practices, resources and knowledge. This collaboration is essential to advance research, integrate the latest findings into clinical practice and ensure that patients receive the most effective treatment. <\/p>\n\n\n\n

EUnetCCC contributes to:<\/p>\n\n\n\n